Li Bai

No. 8, Youanmenwai Street
Fengtai, 100069, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Plasma galectin-3 can be considered as a non-invasive marker to predict the prognosis of ACLF patients with new typing.

Plasma galectin-3 can be considered as a non-invasive marker to predict the prognosis of ACLF patients with new typing.

Journal: Scientific reports
Published: August 23, 2024

Association between serum sphingolipids and necroinflammation of liver tissue pathology in chronic hepatitis B.

Association between serum sphingolipids and necroinflammation of liver tissue pathology in chronic hepatitis B.

Journal: International journal of medical sciences
Published: June 05, 2022

Galectin-3 critically mediates the hepatoprotection conferred by M2-like macrophages in ACLF by inhibiting pyroptosis but not necroptosis signalling.

Galectin-3 critically mediates the hepatoprotection conferred by M2-like macrophages in ACLF by inhibiting pyroptosis but not necroptosis signalling.

Journal: Cell death & disease
Published: May 08, 2022

Dynamic changes of phenotype and function of natural killer cells in peripheral blood before and after thermal ablation of hepatitis B associated hepatocellular carcinoma and their correlation with tumor recurrence.

Dynamic changes of phenotype and function of natural killer cells in peripheral blood before and after thermal ablation of hepatitis B associated hepatocellular carcinoma and their correlation with tumor recurrence.

Journal: BMC cancer
Published: March 10, 2022

Serum HBV DNA plus RNA reflecting cccDNA level before and during NAs treatment in HBeAg positive CHB patients.

Serum HBV DNA plus RNA reflecting cccDNA level before and during NAs treatment in HBeAg positive CHB patients.

Journal: International journal of medical sciences
Published: February 02, 2022

Serum HBV RNA predicts HBeAg clearance and seroconversion in patients with chronic hepatitis B treated with nucleos(t)ide analogues.

Serum HBV RNA predicts HBeAg clearance and seroconversion in patients with chronic hepatitis B treated with nucleos(t)ide analogues.

Journal: Journal of viral hepatitis
Published: August 02, 2021

M2-like macrophages exert hepatoprotection in acute-on-chronic liver failure through inhibiting necroptosis-S100A9-necroinflammation axis.

M2-like macrophages exert hepatoprotection in acute-on-chronic liver failure through inhibiting necroptosis-S100A9-necroinflammation axis.

Journal: Cell death & disease
Published: October 08, 2020

Upregulation of Serum Sphingosine (d18:1)-1-P Potentially Contributes to Distinguish HCC Including AFP-Negative HCC From Cirrhosis.

Upregulation of Serum Sphingosine (d18:1)-1-P Potentially Contributes to Distinguish HCC Including AFP-Negative HCC From Cirrhosis.

Journal: Frontiers in oncology
Published: March 02, 2020

Combined Effects of UGT1A1 and SLCO1B1 Variants on Chinese Adult Mild Unconjugated Hyperbilirubinemia.

Combined Effects of UGT1A1 and SLCO1B1 Variants on Chinese Adult Mild Unconjugated Hyperbilirubinemia.

Journal: Frontiers in genetics
Published: July 28, 2019

Phenotypic switch of human and mouse macrophages and resultant effects on apoptosis resistance in hepatocytes.

Phenotypic switch of human and mouse macrophages and resultant effects on apoptosis resistance in hepatocytes.

Journal: Innate immunity
Published: February 26, 2019

Cellular Mechanisms of Hepatoprotection Mediated by M2-Like Macrophages.

Cellular Mechanisms of Hepatoprotection Mediated by M2-Like Macrophages.

Journal: Medical science monitor : international medical journal of experimental and clinical research
Published: May 01, 2018

Glucosylceramide synthase regulates the proliferation and apoptosis of liver cells in vitro by Bcl‑2/Bax pathway.

Glucosylceramide synthase regulates the proliferation and apoptosis of liver cells in vitro by Bcl‑2/Bax pathway.

Journal: Molecular medicine reports
Published: April 27, 2017
Showing 1-12 of 15

Last Updated: 09/26/2026